Clinical Trial Update: HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) [NA]

View source ↗

Summary

This entry outlines the HIMARS trial evaluating highly metastatic life-prolonging therapy with stereotactic radiotherapy for bone and lymph node metastases in m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Prostate Cancer Metastatic Disease, Oligometastatic Prostate Cancer (OMPC) | NA | Status: NOT_YET_RECRUITING